Mark Rosenbloom

Chief Medical Officer at Lifeforce Medical Institute - Evanston, Illinois, United States

Mark Rosenbloom's Colleagues at Lifeforce Medical Institute
Mark Rosenbloom's Contact Details
HQ
Location
Chicago,Illinois,United States
Company
Lifeforce Medical Institute
Mark Rosenbloom's Company Details
Lifeforce Medical Institute logo, Lifeforce Medical Institute contact details

Lifeforce Medical Institute

Evanston, Illinois, United States • 5 Employees
Medical Practice

LIFEFORCE Medical Institute goes far beyond providing 'Testosterone for Men' and bio-identical Hormone Replacement Therapy (HRT) for women. We also offer a variety of healthy aging supplements, prescriptions, anti-aging and age management programs, tests and fitness protocols that help radically improve health and 'defy aging'. Dr. Mark Rosenbloom Founded and based LIFEFORCE in the Chicago area after years of research on healthy aging, which included studies of other companies in the field such as Bodylogic and Cenegenics. Once he was certain he could dramatically improve upon the services offered by these other companies, he launched LIFEFORCE. Dr. Rosenbloom is certified by the Cenegenics Medical Institute as a "Cenegenics-Trained Age Management Medicine Physician." He is also the winner of multiple academic awards, including the prestigious Sigmund S. Winton award in Biochemistry, and he is a recognized expert and author on vitamin toxicity, medical error reduction, and medical informatics.

Details about Lifeforce Medical Institute
Frequently Asked Questions about Mark Rosenbloom
Mark Rosenbloom currently works for Lifeforce Medical Institute.
Mark Rosenbloom's role at Lifeforce Medical Institute is Chief Medical Officer.
Mark Rosenbloom's email address is ***@lifeforcemed.com. To view Mark Rosenbloom's full email address, please signup to ConnectPlex.
Mark Rosenbloom works in the Medical Practice industry.
Mark Rosenbloom's colleagues at Lifeforce Medical Institute are and others.
Mark Rosenbloom's phone number is
See more information about Mark Rosenbloom